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Sonographically-Guided 14-Gauge Core
Needle Biopsy for Papillary Lesions 
of the Breast
Objective: We wanted to assess the need for surgical excising papillary lesions
of the breast that were diagnosed upon sonographically guided 14-gauge core
needle biopsy.
Materials and Methods: Sixty-nine women (age range: 25 74 years, mean
age: 51.7 years) with 69 papillary lesions (4.9%) were diagnosed and followed
after performing sonographically guided 14-gauge core needle biopsies. Surgical
excision was performed for 44 (64%) of 69 papillary lesions, and 25 lesions were
followed with imaging studies (range: 6 46 months, mean: 17.9 months). The
histologic findings upon core biopsy were compared with the surgical, imaging
and follow-up findings. 
Results: Core needle biopsies of 69 lesions yielded tissue that was classified
as benign for 43 lesions, atypical for 18 lesions and malignant for eight lesions. Of
the 43 lesions that yielded benign papilloma upon core needle biopsy, one had
intraductal papillary carcinoma found upon surgery. An immediate surgical biopsy
was recommended for this lesion because of the imaging-histologic discordance.
No additional carcinoma was found during the imaging follow-up. Surgical exci-
sion was performed for 17 atypical papillary lesions, and this revealed intraductal
(n = 6) or invasive (n = 2) papillary carcinoma in 8 (47%) lesions. Of the seven
intraductal papillary carcinomas, surgery revealed invasive papillary carcinoma in
one (14%). 
Conclusion: Our results suggest that papillary lesions of the breast that are
diagnosed as benign upon sonographically guided 14-gauge core needle biopsy
can be followed when the results are concordant with the imaging findings. 
apillary lesions of the breast account for less than 10% of all benign
breast neoplasms that are biopsied, and they are 1 2% of all breast
carcinomas (1 4). Papillary breast proliferations form a spectrum of
lesions that are difficult to diagnose both with using the excision biopsy specimens and
the diagnostic core biopsy specimens (5, 6). Surgical excision has been used to
establish the diagnosis in most cases. However, the results of recent studies have
suggested that percutaneous core biopsy with imaging concordance may be sufficient
for the diagnosis and management of papillary lesions (7, 8). However, most of these
studies generally used stereotactic guidance and the number of cases was relatively
small. 
The advantages of sonography as a guidance modality for percutaneous breast
biopsy include the lack of ionization radiation, the use of non-dedicated equipment
and the real-time needle visualization. For lesions amenable to either stereotactic or
sonographically guided biopsy, sonographically guided biopsy is preferable in terms of
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Ppatient comfort, the procedure time and cost (9, 10).
The purpose of our study was to assess the need for
surgical excising papillary lesions of the breast that were
diagnosed via sonographically guided 14-gauge core
needle biopsy. 
MATERIALS AND METHODS
Patients
Between January 2001 and April 2005, sonographically
guided 14-gauge core needle biopsies were performed on
1,566 consecutive lesions at our institution, and 76 (4.9%)
of these were diagnosed as papillary lesions. Using an
outcomes audit of our biopsy database, we retrospectively
identified all the cases of papillary lesions, including
papilloma, papillomatosis, atypical papilloma, noninvasive
papillary carcinoma and invasive papillary carcinoma (6).
Seven of the 76 cases were lost to follow-up and so they
were excluded from this study. The remaining 69 papillary
lesions in 69 women (age range: 25 74 years, mean age:
51.7 years) constituted our study population. Of the 69
patients, 29 (42%) presented with palpable mass, three
(4%) with breast pain, nine (13%) with nipple discharge,
11 (16%) with screening mammographic abnormalities and
17 women (25%) with mammographic dense breast had
sonographic abnormality. Surgical excision was performed
for 44 (64%) of 69 papillary lesions. The remaining 25
(36%) lesions underwent imaging follow-up and the mean
duration of follow-up was 17.9 months (range: 6 46
months). 
Biopsy
All biopsies were guided using high-resolution sonogra-
phy units with 10- or 12-MHz linear transducers (Voluson
730, Kretz, Austria; HDI 5000, Advanced Technology
Laboratories, Bothell, WA) with the patient in the supine
or supine oblique position. The biopsies were performed
using a freehand technique with a 14-gauge automated
needle (Bard Peripheral Technologies, Convinton, GA)
and a spring-loaded biopsy gun (Pro-Mag 2.2, Manan
Medical Products, Northbrook, IL). The biopsy procedures
were performed by four fellows and three staff radiolo-
gists; the radiologists each had between 2 8 years of
experience with breast imaging. The mean number of core
samples obtained with the 14-gauge automated gun was
five (range: 3 10). 
Image Evaluation
The imaging findings for all lesions were retrospectively
reviewed by two radiologists working in consensus. All the
lesions were evaluated for size. The US appearances of the
lesions were characterized according to the American
College of Radiology (ACR) Breast Imaging Reporting and
Data System (BI-RADS) lexicon and the final assessment
categories (11, 12).
Concordance and Management
The pathology results were prospectively compared with
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Fig. 1. An asymptomatic 52-year-old woman with benign papilloma upon core needle biopsy. 
A. Collimated photograph of the mediolateral oblique mammogram reveals no focal abnormality in the left subareolar area. 
B. Sonogram reveals a 7 mm oval mass (arrow) in the left subareolar area. This finding was thought to be concordant with the benign
histology of the core biopsy. A subsequent surgical rebiopsy due to the patient’s concern also revealed benign papilloma.
A Bthe relevant imaging findings to determine concordance or
discordance of the biopsy results. Decisions were made by
two radiologists working in consensus. Benign pathology
was considered concordant if no imaging features that
were highly suspicious for malignancy were present,
accurate targeting of the needle was shown, adequate
samples were obtained and the pathology results suggested
a process known to manifest as a mass (7, 8). The findings
were discordant when a BI-RADS category of 5 (highly
suggestive of malignancy) was given to the lesion at
imaging and the corresponding histologic finding was
benign. If a lesion’s imaging was determined to be concor-
dant with benign pathology, then 6, 12 or 24 months of
follow-up was recommended (Fig. 1). All the pathology
results that revealed atypia, intraductal or invasive
carcinoma received recommendations for surgical excision.
Those benign lesions for which an operation was requested
by the pathologist and radiologist, due to imaging-
pathologic discordance, were also excised. 
Outcome Analysis
“Histologic underestimation” was defined as a lesion
yielding atypical ductal hyperplasia (ADH) upon percuta-
neous biopsy and carcinoma upon surgery (ADH underes-
timation), or a lesion that yielded ductal carcinoma in situ
(DCIS) upon core needle biopsy and invasive carcinoma
upon surgery (DCIS underestimation) (13, 14). The
underestimation rate of ADH or DCIS was determined by
dividing the total number of lesions, for which excisional
biopsy was performed, by the number of lesions that
proved to be DCIS or invasive carcinoma upon excision.
When repeat biopsy was performed, the time interval and
the reason for the second biopsy were recorded. An
immediate rebiopsy was considered when the repeat
biopsy was performed before the first sonographic follow-
up. A delayed rebiopsy was considered when the repeat
biopsy was performed after sonographic follow-up. The
repeat biopsy rate was determined by dividing the total
number of core needle biopsies by the number of repeat
biopsies. The false negative rate was determined by
dividing the total number of carcinomas found upon
subsequent biopsy by the number of those lesions that
were previously benign upon core needle biopsy (15 17). 
RESULTS
Forty-three benign papillomas (62%), 18 atypical
papillomas (26%), seven intraductal papillary carcinomas
(10%), and one invasive papillary carcinoma (2%) were
diagnosed upon core needle biopsy. All the lesions with a
histologic diagnosis of malignancy (n = 8) or atypia (n =
17), except one atypical papilloma, upon core needle
biopsy were surgically excised. Of the 43 lesions that were
diagnosed upon core needle biopsy as benign, 19 lesions
underwent surgical excision. The histologic findings upon
core needle biopsy and surgical excision are given in
Tables 1 and 2. 
At sonography, the mean size was 1.3 cm (range: 0.5
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Table 1. Comparison of the Sonographically Guided 14-gauge Core Needle Biopsy Results with Surgical Results and Follow-
up in 69 Papillary Lesions
Histologic Findings at Excision
Histologic Findings at Core Biopsy
Benign Atypical Lesion Intraductal Carcinoma Invasive Carcinoma Follow-up only
Benign (n = 43) 15 3 1 0 24
Atypical Lesion (n = 18) 2 7 6 2 1
Intraductal Carcinoma (n = 7) 0 1 5 1 0
Invasive Carcinoma (n = 1) 0 0 0 1 0
Table 2. Comparison of the BI-RADS Categories and the Surgical and Follow-up Results in 69 Papillary Lesions
Histologic Findings at Excision
Final Assessment*
Benign Atypical Lesion IntraductalCarcinoma Invasive Carcinoma Follow-up only
Category 3 (n = 9) 5 1 0 0 03
Category 4a (n = 47) 7 9 7 3 21
Category 4b, 4c (n = 12) 5 1 4 1 01
Category 5 (n = 1) 0 0 1 0 00
Note. *Final assessment categories were also provided according to the American College of Radiology Breast Imaging Reporting and Data System (BI-
RADS); category 3 is probably benign lesions, category 4a is low suspicious lesions, category 4b or 4c is moderate suspicious lesions and category 5 is
highly suggestive of malignancy. 
One atypical papilloma was stable at 24 months of imaging follow-up.3.8 cm) for all the papillary lesions. These lesions
manifested sonographically as hypoechoic solid masses in
40 patients, intracystic masses in three patients, complex
masses with solid and cystic components in nine patients,
and as a mass within a dilated duct in 17 patients. Six
lesions were round, 10 were oval and 53 were irregular in
shape. The margins were circumscribed in 16 lesions and
noncircumscribed in 53 lesions. The final assessment of 69
lesions, based on the combined mammographic and
sonographic findings, was category 3 (probably benign
lesions) for nine masses (13%), category 4a (low suspicion
lesions) for 47 masses (68%), category 4b or 4c (moderate
suspicion lesions) for 12 masses (18%) and category 5
(highly suggestive of malignancy) for one mass (1%) (Table
2). 
The imaging findings and the histopathologic findings for
42 of the 43 benign lesions (Fig. 1), for all 18 atypical
lesions, and for all eight malignant lesions were concor-
dant. There was discordance between the imaging findings
and the histopathologic findings for one of the benign
lesions upon core needle biopsy (Fig. 2). The
mammograms and sonographic findings demonstrated a
1.6 cm irregular hypoechoic mass and it was assessed as
category 5, that is, highly suggestive of malignancy.
Subsequent surgical excision and histopathologic evalua-
tion of this lesion revealed an intraductal papillary
carcinoma. All but one of the atypical papillomas
underwent excision. The surgical biopsy results revealed
benign findings without atypia in two lesions (12%),
atypical papilloma in seven lesions (41%), intraductal
papillary carcinoma in six lesions (35%), and invasive
papillary carcinoma in two lesions (12%) (Table 1). The
ADH underestimation rate was 47% (8/17). Of the seven
lesions yielding intraductal papillary carcinoma upon core
needle biopsy, surgical excision revealed intraductal
papillary carcinoma in five lesions (71%), invasive
papillary carcinoma in one lesion (14%) and one atypia
without carcinoma. Therefore, the DCIS underestimation
rate was 14% (1/7). 
Repeat biopsy was performed for 19 of the 43 patients
with benign papillary lesions and for 17 of the 18 patients
with atypical papillary lesions. For repeat biopsy, surgical
excision was done in all cases and this was performed
because of the patient’s or physicians’ concern (n = 18),
imaging-histologic discordance (n = 1), and atypia findings
(n = 17). All the repeat biopsies, except one, were
performed immediately after the first core needle biopsy.
Delayed repeat biopsy was performed for only one benign
lesion because of the patient’s concern. The repeat biopsy
rate was 52% (36/69); the false negative rate was 6.3%
(1/19).
Twenty-four (56%) of the 43 lesions that were diagnosed
as benign were not surgically excised and they underwent
imaging follow-up (range: 6 46 months; mean: 17.9
months). One atypical papilloma that was not surgically
excised underwent 24 months of imaging follow-up. No
additional carcinoma was detected during the follow-up
period. All the lesions were stable (n = 20) or they had
US-Guided 14-G Core Needle Biopsy for Papillary Breast Lesions 
Korean J Radiol 8(3), June 2007 209
Fig. 2. An asymptomatic 34-year-old woman with benign papilloma upon core needle biopsy. 
A. Collimated photograph of the craniocaudal mammogram reveals a 2 cm area of architectural distortion with central density (arrow) in
the right subareolar area. 
B. Sonogram reveals a 1.6 cm irregular hypoechoic mass (arrow) with a spiculated margin and ductal extension. A subsequent surgical
rebiopy was recommended due to the imaging-histologic discordance, and it revealed intraductal papillary carcinoma.
ABdecreased in size (n = 5). 
DISCUSSION
In our series, 4.9% (76/1,566) of the sonographically
guided core needle biopsies performed at our institution
revealed papillary lesions. This frequency is same as the
4.9% (36/734) by Liberman et al. (7) and it is higher than
the 3.2% (34/1,077) by Mercado et al. (18). Our study
included 17 (25%) sonographic abnormalities in patients
with mammographic dense breast, while most of the cases
in the other studies were detected by mammographic
abnormalities. Lesions that are neither palpable nor
mammographically visible can be detected on sonography
during the evaluation of unrelated mammographic or
clinical findings (10). Recent studies have reported that
women with mammographically dense breasts have a
considerably increased rate for detecting breast cancer
when whole-breast sonography is performed (19 21). 
The results of the previously published series, including
our own data, are shown in Table 3. The outcomes of
sonographically guided 14-gauge core needle biopsy in our
study were not inferior to the stereotactic guided 14- and
11-gauge needle biopsies in terms of repeat biopsy and the
false negative rate. In a study by Mercado et al. (18), an
11-gauge vacuum-assisted biopsy device was used to
perform all the percutaneous biopsies. Previous studies
have demonstrated that a larger tissue sample is obtained
per core specimen with the 11-gauge stereotactic
directional vacuum-assisted biopsy technique versus the
14-gauge core biopsy technique (14, 16). This provides for
a larger lesion sample, which may help to more accurately
identify lesions. Therefore, Mercado’s outcomes would
seem to be better than some of the other studies in terms
of the repeat biopsy rate and the ADH underestimation
rate. 
Controversy still persists regarding the need for excision
of papillomas that are diagnosed upon percutaneous breast
biopsy (22, 23). In a recent study by Liberman et al. (23),
cancer was found in five (14%) of the 35 lesions that
yielded a benign, concordant diagnosis of papilloma upon
percutaneous biopsy. Surgery also revealed six (17%)
high-risk lesions, including atypical ductal hyperplasia (n =
3), radial scar (n = 2), and lobular carcinoma in situ (n = 1).
However, our findings support the previous reports that
lesions diagnosed as benign papillomas upon core needle
biopsy can be safely managed with clinical and imaging
follow-up, and they do not necessarily require surgical
excision (8). In our series, one papillary lesion diagnosed as
benign upon sonographically guided 14-gauge core needle
biopsy was subsequently found to be malignant.
Immediate repeat biopsy was recommended in this case
due to the imaging-histologic discordance. In a study by
Mercado et al. (22), two papillary lesions that were
diagnosed as benign upon core needle biopsies were
subsequently diagnosed as malignant by surgical excision.
Immediate repeat biopsy was recommended in these cases
due to the imaging-histologic discordance. Their results and
our results confirm the importance of imaging-histologic
correlation after core needle biopsy for managing papillary
lesions that are diagnosed as benign. In our study, eight
(47%) of the 17 atypical biopsies were upgraded to
intraductal or invasive carcinoma after surgical excision.
Hence, the diagnosis of atypical papilloma or atypical
features upon sonographically guided 14-gauge core
needle biopsy clearly calls for surgical excision.
Underestimation upon core biopsy is an inherent limitation
of this technique and this has well been documented (16,
17). This understaging of malignancy upon sonographically
guided core biopsy has been shown to decrease with the
increasing number of tissue samples, with the use of larger
biopsy needles and with the use of a vacuum-assisted
biopsy device (14, 15). 
Our study has the following limitations. Seven of the 76
papillary lesions were lost to follow-up and so they were
excluded from this study. Excluding these cases could have
increased the accuracy of 14-gauge sonographically guided
core needle biopsy. When diagnosing a lesion as a benign
Ko et al.
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Table 3. Results of the Published Series on Imaging-Guided Core Needle Biopsy for Papillary Lesions
Author and  No. of  Proportion of  Needle  Malignant  Repeat  False  Underestimation 
Reference  Lesions Sonographic  Size  Findings at Core  Biopsy  Negative Rate* (%)
No. Guidance (%) (gauge) Biopsies (%) Rate (%) Rate (%) ADH DCIS
Liberman et al. (7) 26 29 14 and 11 27 58 9 (1/11) 30 (3/10) 43 (3/7)
Mercado et al. (18)  26 0 11 31 46 11 (1/9) 0 (0/6) 25 (2/8)
Rosen et al. (8) 46 40 14 and 11 4 30 0 (0/3) 38 (3/8) 0 (0/3)
Present study 69 100 14 12 52 6 (1/16) 47 (8/17) 14 (1/7)
Note. *A histologic underestimation was defined as a lesion yielding atypical ductal hyperplasia upon percutaneous biopsy and carcinoma upon surgery 
(ADH underestimation) or yielding ductal carcinoma in situ (DCIS) upon core needle biopsy and invasive carcinoma upon surgery (DCIS underestimation).US-Guided 14-G Core Needle Biopsy for Papillary Breast Lesions 
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lesion with core needle biopsy, we recommended imaging
follow-up and 56% (26/43) of the lesions in our study
underwent imaging follow-up with the mean duration of
17.9 months (range: 6 46 months). This was insufficient to
accurately estimate the false negative rate. 
In conclusion, sonographically guided 14-gauge core
needle biopsy of a benign papillary lesion can be reliable
when the histological/pathological result is concordant with
the imaging characteristics. Surgical excision is indicated
for atypical papillary lesions because performing only
percutaneous biopsy may underestimate the degree of
disease in these cases, yet further study is necessary to
confirm our findings. 
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